二十一世纪机械通气急性呼吸窘迫综合征的流行病学趋势:一项全国性、基于人群的回顾性研究
该研究利用西班牙最低基本数据集(覆盖约99.5%),回顾性分析2000年1月1日至2022年12月31日全部机械通气ARDS(MV-ARDS)住院记录,共93,192例。MV-ARDS发病率为2.96–20.14/10万人口/年,2021年达峰;住院死亡率38.0%–55.0%,呈下降趋势;人均费用上升,2011年达峰值€42,812后稳定在约€30,000–€40,000。COVID-19大流行期间住院时间延长(p < 0.001)、住院死亡率下降(p < 0.001),肥胖、糖尿病及真菌或病毒病因比例增加。作者认为MBDS数据可增进对ARDS的理解并指导未来研究。
要点
- 2000–2022年西班牙MV-ARDS共93,192例,发病率为2.96–20.14/10万人口/年,2021年达峰。
- 住院死亡率介于38.0%–55.0%,呈下降趋势;人均费用上升,2011年峰值€42,812后稳定在约€30,000–€40,000。
- COVID-19大流行期间住院时间延长(p < 0.001),住院死亡率下降(p < 0.001)。
- 肥胖、糖尿病及真菌或病毒病因的患者比例增加。
- 作者认为MBDS数据可增进对ARDS的理解并指导未来研究。
适用人群与场景
- 西班牙医院2000年1月1日至2022年12月31日所有MV-ARDS住院患者,基于MBDS记录,估计覆盖率99.5%。
研究设计与关键结果
- 全国性、基于人群的回顾性研究,分析93,192例新诊断MV-ARDS记录,MBDS估计覆盖率99.5%。
- MV-ARDS发病率为2.96–20.14/10万人口/年,2021年达峰。
- 住院死亡率38.0%–55.0%,呈下降趋势;人均费用上升,2011年峰值€42,812后稳定在约€30,000–€40,000。
- COVID-19大流行期间住院时间延长(p < 0.001),住院死亡率下降(p < 0.001)。
- 肥胖、糖尿病及真菌或病毒病因的患者比例增加。
证据类型、等级与局限
- 证据类型:全国性、基于人群的回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为MBDS数据可增进对ARDS的理解并指导未来研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Acute respiratory distress syndrome (ARDS) is a prevalent respiratory condition associated with significant mortality. Current literature on ARDS epidemiology reports a wide range of incidence (7.2-78.9/100,000 population/year), hospital mortality (32-51%), and associated costs ($8476-$547,974). We have analyzed epidemiological trends of mechanically ventilated ARDS (MV-ARDS) in Spain from 2000 to 2022 using the Minimum Basic Data Set (MBDS), focusing on MV-ARDS incidence, associated mortality, and economic impact.
METHODS: We conducted a nationwide, population-based retrospective study of all hospitalizations for MV-ARDS in Spanish hospitals-from January 1, 2000 to December 31, 2022-using MBDS records, with an estimated coverage of 99.5%. The study reports MV-ARDS incidence per 100,000 population/year, hospital mortality rate, and mean cost per patient. We also considered the effect of COVID-19 on MV-ARDS epidemiology.
RESULTS: We analyzed 93,192 records of patients with a new diagnosis of MV-ARDS during the study period. MV-ARDS incidence ranged from 2.96 to 20.14/100,000 population-years, peaking in 2021. Mortality ranged between 38.0 and 55.0%, showing a declining trend, while the cost per patient increased, stabilizing ~€30,000-€40,000 after reaching a peak of €42,812 in 2011. During the COVID-19 pandemic, hospital stay lengthened (p < 0.001), while hospital mortality decreased (p < 0.001). There was an increased proportion of patients with obesity and diabetes mellitus, with fungal or viral etiologies.
CONCLUSION: This is the largest epidemiological study on ARDS in Europe. MV-ARDS incidence has stabilized in recent years, with mortality showing a declining trend. ARDS-related costs have increased nearly fourfold. MBDS data could enhance ARDS understanding and guide future studies.
参考来源
- Bardají-Carrillo M, López-Herrero R, Aguilar G, et al. Epidemiological trends of mechanically ventilated acute respiratory distress syndrome in the twenty-first century: a nationwide, population-based retrospective study. J Intensive Care. 2025. PMID: 39962546. doi:10.1186/s40560-025-00781-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。